Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Monsoon
Petrol Diesel Prices
Enforcement Directorate (ED)
Narcotics Control Bureau
Sidhu Moose Wala
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices
India

After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices

After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices
Written by Siddhant Pandey
Jun 10, 2021, 03:53 pm 3 min read
After updating vaccine policy, Centre may renegotiate Covishield, COVAXIN prices
The Centre is currently paying Rs. 150 per dose for both Covishield and COVAXIN.

After India's COVID-19 vaccination policy was updated this week, the central government is likely to renegotiate prices for vaccines, a report suggested. The Centre is currently paying Rs. 150 per dose for both Covishield (manufactured by the Serum Institute of India) and COVAXIN (manufactured by Bharat Biotech). The new price is reportedly yet to be decided. Here are more details.

New policy
What is the new vaccination policy?

Under the new policy, the Centre will procure 75% of all vaccine doses and provide them to states/union territories for free. The remaining would be available to private hospitals at a price. Earlier, 50% of vaccines were going to the Centre (which would be given free to states/UTs), and the remaining 50% was available to states/UTs along with private hospitals at a higher price.

Report
Centre may pay more than Rs. 150/dose: Report

A senior government official told The Indian Express that the Centre is likely to renegotiate prices with Bharat Biotech and SII, but the new price remains undecided. This week, the government said it has placed an advance order for 44 crore doses. The price for this wasn't specified, however, sources told the Hindustan Times that the Centre may have to pay over Rs. 150/dose.

Information
SII losing money by selling doses at Rs. 150: CEO

SII CEO Adar Poonawalla had earlier told CNBC-TV18 that the company is losing money by selling the vaccine at Rs. 150 per dose. "We have to pay 50% of the price to AstraZeneca as royalty," Poonawalla had said.

Changes
New policy to cost Rs. 50,000 crore

The Centre's new vaccination policy will provide free vaccines to all people above the age of 18 years from June 21. The new scheme will likely cost Rs. 50,000 crore, which is higher than the Rs. 35,000 crore budget earmarked by the Centre for vaccines during the Union Budget in February. Finance Minister Nirmala Sitharaman had said the allocation may be increased if required.

Background
How have the prices changed in the past?

When the vaccination drive was launched on January 16, the Centre procured 11 million Covishield doses at Rs. 200/dose and 5.5 million COVAXIN doses at Rs. 206/dose. The prices were later lowered to Rs. 150/dose. Till April, private hospitals were procuring doses at Rs. 250 each from the government. In April, vaccine manufacturers were allowed to fix rates for states and private facilities.

Information
SII, BB fixed higher rates for private players in April

SII fixed Rs. 400/dose for states and Rs. 600/dose for private facilities, while Bharat Biotech had settled on Rs. 600/dose and Rs. 1,200/dose for states and private facilities, respectively. The rates were revised to Rs. 300/dose for Covishield and Rs. 400/dose for COVAXIN for states.

New rates
COVAXIN now world's third most expensive vaccine

Private facilities are being made to procure doses at a higher price to incentivize production by manufacturers. As per a new circular, the price for private hospitals of Covishield has been fixed at Rs. 780/dose, Sputnik V at Rs. 1,145/dose, and COVAXIN at Rs. 1,410/dose. This makes COVAXIN the world's third most expensive vaccine after China's Sinopharm (Rs. 2,080) and Pfizer (Rs. 1,423).

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Vaccine
Coronavirus
COVAXIN
Covishield
Related
Latest
Lord's Test, Day 2: NZ bowl England out for 141
Lord's Test, Day 2: NZ bowl England out for 141 Sports
'Vikram' review: Kamal Haasan's near-perfect comeback is a treat!
'Vikram' review: Kamal Haasan's near-perfect comeback is a treat! Entertainment
Sensex closes at 55,769.23 points, Nifty settles below 16,600 points
Sensex closes at 55,769.23 points, Nifty settles below 16,600 points Business
SRK is man on a mission in Atlee's 'Jawan' teaser
SRK is man on a mission in Atlee's 'Jawan' teaser Entertainment
Elon Musk warns of job cuts at Tesla; pauses hiring
Elon Musk warns of job cuts at Tesla; pauses hiring Business
Vaccine
COVID-19: India logs 2,745 fresh COVID-19 cases, 6 more fatalities
COVID-19: India logs 2,745 fresh COVID-19 cases, 6 more fatalities India
COVID-19: India logs 2,628 fresh cases, 18 more fatalities
COVID-19: India logs 2,628 fresh cases, 18 more fatalities India
COVID-19: India logs 2,124 fresh cases, 17 more deaths
COVID-19: India logs 2,124 fresh cases, 17 more deaths India
COVID-19: India logs 2,487 fresh cases, 13 more fatalities
COVID-19: India logs 2,487 fresh cases, 13 more fatalities India
COVID-19: India logs 2,858 fresh cases, 11 more fatalities
COVID-19: India logs 2,858 fresh cases, 11 more fatalities India
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
More News
Covishield
SII to launch COVID-19 vaccine for children in 6 months
SII to launch COVID-19 vaccine for children in 6 months India
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 9K+ infections; 477 more deaths
COVID-19: India reports 9K+ infections; 477 more deaths India
No quarantine for fully vaccinated Indians in UK from Monday
No quarantine for fully vaccinated Indians in UK from Monday India
Date of birth on Co-WIN certificates for passengers traveling abroad
Date of birth on Co-WIN certificates for passengers traveling abroad India
More News
Related
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
COVID-19: How states are ensuring people get their second doses
COVID-19: How states are ensuring people get their second doses India
80% post-vaccination infections due to Delta variant, says ICMR study
80% post-vaccination infections due to Delta variant, says ICMR study Technology
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022